BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19755437)

  • 21. Intermediate syndrome with delayed distal polyneuropathy from ethyl parathion poisoning.
    Nisse P; Forceville X; Cezard C; Ameri A; Mathieu-Nolf M
    Vet Hum Toxicol; 1998 Dec; 40(6):349-52. PubMed ID: 9830697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose pralidoxime for organophosphorus poisoning.
    Abroug F
    Lancet; 2007 Apr; 369(9571):1426-1427. PubMed ID: 17467505
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is PAM an effective antidote for organophosphate poisoning? Pros: PAM (pralidoxime) is effective for acute poisoning of organophosphorus].
    Kamei T
    Chudoku Kenkyu; 2010 Mar; 23(1):31-5. PubMed ID: 20380319
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antidose therapy for organophosphate poisoning].
    Iseki K
    Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
    [No Abstract]   [Full Text] [Related]  

  • 25. Pralidoxime in the treatment of carbamate intoxication.
    Kurtz PH
    Am J Emerg Med; 1990 Jan; 8(1):68-70. PubMed ID: 2403479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Arafat K; Rajan S; Hasan MY
    Arch Toxicol; 2006 Nov; 80(11):777-84. PubMed ID: 16598495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does pralidoxime affect outcome of management in acute organophosphorus poisoning?
    de Silva HJ; Wijewickrema R; Senanayake N
    Lancet; 1992 May; 339(8802):1136-8. PubMed ID: 1349368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methomyl-induced carbamate poisoning treated with pralidoxime chloride.
    Ekins BR; Geller RJ
    West J Med; 1994 Jul; 161(1):68-70. PubMed ID: 7941519
    [No Abstract]   [Full Text] [Related]  

  • 29. [Poisoning with organophosphate compounds].
    Vos EM; Hens JJ; Lau HS; Boon ES; Bartelink AK
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):34-7. PubMed ID: 11802337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial cholinesterase estimation in carbamate poisoning.
    Pinakini KS; Kumar TS
    J Clin Forensic Med; 2006 Jul; 13(5):274-6. PubMed ID: 16442830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic phosphorus compounds--nerve agents.
    Barthold CL; Schier JG
    Crit Care Clin; 2005 Oct; 21(4):673-89, v-vi. PubMed ID: 16168308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Three cases of organophosphate poisoning treated with pralidoxime iodide and whole-bowel irrigation].
    Fujino Y; Inoue Y; Onodera M; Endo K; Endo S; Nakayama H; Fujita Y
    Chudoku Kenkyu; 2004 Jul; 17(3):273-7. PubMed ID: 15495687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fatal outcome after unintentional overdosing of rivastigmine patches.
    Lövborg H; Jönsson AK; Hägg S
    Curr Drug Saf; 2012 Feb; 7(1):30-2. PubMed ID: 22663954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning.
    Güven M; Sungur M; Eser B; Sari I; Altuntaş F
    J Toxicol Clin Toxicol; 2004; 42(5):617-23. PubMed ID: 15462154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarin induced lung pathology and protection by standard therapy regime.
    Pant SC; Vijayaraghavan R; Das Gupta S
    Biomed Environ Sci; 1993 Jun; 6(2):103-11. PubMed ID: 8397893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of magnesium sulfate in acute organophosphate pesticide poisoning.
    Basher A; Rahman SH; Ghose A; Arif SM; Faiz MA; Dawson AH
    Clin Toxicol (Phila); 2013 Jan; 51(1):35-40. PubMed ID: 23311540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivastigmine exposure provided by a transdermal patch versus capsules.
    Mercier F; Lefèvre G; Huang HL; Schmidli H; Amzal B; Appel-Dingemanse S
    Curr Med Res Opin; 2007 Dec; 23(12):3199-204. PubMed ID: 18001519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivastigmine for Alzheimer's disease.
    Desai AK; Grossberg GT
    Expert Rev Neurother; 2005 Sep; 5(5):563-80. PubMed ID: 16162080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.